OptiNose, Inc. (NASDAQ:OPTN) Q4 2021 Earnings Conference Call March 8, 2022 8:00 AM ET Company Participants Jonathan Neely - Vice President, Investor Relations & Business Operations Peter Miller - Chief Executive Officer Ramy Mahmoud - President & Chief Operating Officer Victor Clavelli - Chief Commercial Officer Keith Goldan - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Dave Amsellem - Piper Sandler Gary Nachman - BMO Capital Markets Operator Good day, and thank ...

Building a Leading ENT / Allergy Specialty Company Corporate Presentation March 8, 2022 This presentation and our accompanying remarks contain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements that are not historical facts are hereby identified as forward-looking statements for this purpose and include, among others, statements relating to: potential for continued XHANCE prescription and net revenue growth and factors supporting such ...

OptiNose, Inc. (NASDAQ:OPTN) Q3 2021 Earnings Conference Call November 16, 2021 8:30 AM ET Company Participants Jonathan Neely - VP, IR & Business Operations Peter Miller - CEO & Director Keith Goldan - CFO Ramy Mahmoud - President & COO Conference Call Participants Gary Nachman - BMO Capital Markets David Amsellem - Piper Sandler David Steinberg - Jefferies Ken Cacciatore – Cowen Ladies and gentlemen, thank you for standing by, and welcome to the OptiNose Q3 2021 Earnings Call. At this time, all participan ...

OptiNose, Inc. (NASDAQ:OPTN) Q2 2021 Earnings Conference Call August 11, 2021 11:00 AM ET Company Participants Jonathan Neely - VP, IR & Business Operations Peter Miller - CEO & Director Keith Goldan - CFO Ramy Mahmoud - President & COO Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Steve Daddeo - RBC Capital Markets Kenneth Cacciatore - Cowen and Company David Amsellem - Piper Sandler & Co. Operator Good morning, ladies and gentlemen, and welcome to the OptiNose Second Quarter 2021 E ...

Building a Leading ENT / Allergy Specialty Company Corporate Presentation August 11, 2021 This presentation and our accompanying remarks contain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements that are not historical facts are hereby identified as forward-looking statements for this purpose and include, among others, statements relating to: potential for continued XHANCE prescription and net revenue growth and factors supporting su ...

| --- | --- | --- | --- | |-------|-------------------|----------------------------------|-------| | | | | | | | Specialty Company | Building a Leading ENT / Allergy | | | | | Corporate Presentation | | | | | May 5, 2021 | | Forward-Looking Statements This presentation and our accompanying remarks contain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements that are not historical facts are hereby identified as forward-looking statement ...

OptiNose, Inc. (NASDAQ:OPTN) Q1 2021 Earnings Conference Call May 5, 2021 8:00 AM ET Company Participants Jonathan Neely - VP, IR & Business Operations Keith Goldan - Chief Financial Officer Peter Miller - Chief Executive Officer Ramy Mahmoud - President and Chief Operating Officer Victor Clavelli - Chief Commercial Officer Conference Call Participants Gary Nachman - BMO Capital Markets Georgi Yordanov - Cowen and Company Ed Chung - Jefferies Brandon Folkes - Cantor Fitzgerald Daniel Busby - RBC Capital Mar ...

OptiNose, Inc. (NASDAQ:OPTN) Q4 2020 Earnings Conference Call March 3, 2021 8:00 AM ET Company Participants Jonathan Neely – Vice President-Investor Relations Peter Miller – Chief Executive Officer Keith Goldan – Chief Financial Officer Ramy Mahmoud – President and Chief Operating Officer Vic Clavelli – Chief Commercial Officer Conference Call Participants Steve Daddeo – RBC Capital Markets Gary Nachman – BMO Capital Markets Brandon Folkes – Cantor Fitzgerald David Amsellem – Piper Sandler Georgi Yordanov – ...

OptiNose, Inc. (NASDAQ:OPTN) Q3 2020 Results Conference Call November 5, 2020 8:00 AM ET Company Participants Jonathan Neely - Vice President, Investor Relations Peter Miller - Chief Executive Officer Ramy Mahmoud - President and Chief Operating Officer Vic Clavelli - Chief Commercial Officer Keith Goldan - Chief Financial Officer Conference Call Participants Stacy Ku - Cowen David Steinberg - Jefferies Brandon Folkes - Cantor Fitzgerald Rafay Sardar - BMO Operator Ladies and gentlemen, thank you for standi ...

| --- | --- | --- | |-------|-----------------------------------------------------|-------| | | | | | | Building a Leading ENT / Allergy Specialty Company | | | | Corporate Presentation | | | | November 5, 2020 | | Forward-Looking Statements This presentation and our accompanying remarks contain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements that are not historical facts are hereby identified as forward-looking statements for this ...